14-day Premium Trial Subscription Try For FreeTry Free
CAMBRIDGE, Mass. , June 3, 2022  /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, toda

Expert Ratings for Akebia Therapeutics

03:03pm, Monday, 16'th May 2022 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Akebia Therapeutics (NASDAQ:AKBA) stock. These analysts are typically employed by large Wall Street banks and tasked with understandi
Akebia Therapeutics Inc (NASDAQ: AKBA) and Otsuka Holdings (OTC: OTSKY) separately announced to call for licensing and co-development agreement for vadadustat. Otsuka sent a written notice to Akeb

What to Know About Buying Penny Stocks on May 11th 

12:30pm, Wednesday, 11'th May 2022 PennyStocks
Here's what you need to know about trading penny stocks today The post What to Know About Buying Penny Stocks on May 11th  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS

What to Know About Buying Penny Stocks on May 11th

08:30am, Wednesday, 11'th May 2022
Here's what you need to know about trading penny stocks today The post What to Know About Buying Penny Stocks on May 11th  appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt

Akebia Therapeutics (AKBA) Reports Q1 Loss, Tops Revenue Estimates

10:25pm, Monday, 09'th May 2022 Zacks Investment Research
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -29.63% and 39.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Akebia Therapeutics, Inc. (NASDAQ:AKBA ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Mercedes Carrasco - Director, Corporate Communications John Butler - CEO, Presiden

Zoetis (ZTS) Tops Q1 Earnings and Revenue Estimates

12:25pm, Thursday, 05'th May 2022 Zacks Investment Research
Zoetis (ZTS) delivered earnings and revenue surprises of 8.20% and 0.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Akebia Therapeutics (AKBA) Expected to Beat Earnings Estimates: Should You Buy?

07:00pm, Monday, 02'nd May 2022 Zacks Investment Research
Akebia Therapeutics (AKBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy Now? 5 Stocks Under $1 To Watch In April appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy Now?

See Why Does HC Wainwright Maintain Neutral On Akebia Stock

06:38pm, Thursday, 07'th Apr 2022 Benzinga
Akebia Therapeutics Inc (NASDAQ: AKBA) announced three poster presentations at the National Kidney Foundation (NKF) Spring Clinical Meetings 2022.  Poster data demonstrated that overall, vadadustat
Biopharma stocks are sensitive to a key binary event called the PDUFA date, the date by which the Food and Drug Administration is required to give its verdict on a regulatory application filed with it
Upgrades Raymond James upgraded the previous rating for Starwood Property Trust Inc (NYSE:STWD) from Outperform to Strong Buy. For the fourth quarter, Starwood Property Trust had an EPS of $1.10, comp

6 Stocks Halted In Wednesday's Session

09:12pm, Wednesday, 30'th Mar 2022 Benzinga
A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and br
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE